Fig. 6.

Prognostic value of hsa-mir-383, hsa-mir-615, or hsa-mir-877 in both cohorts. (a) In TCGA patients, Kaplan–Meier Survival analysis result indicated that different expression levels of hsa-mir-383 led to significantly different survival rates (log-rank test p-value = 0.058), while no significant survival differences were observed between the high and low expression set of hsa-mir-615 (log-rank test p-value = 0.57) or hsa-mir-877 (log-rank test p-value = 0.14); (b). In validation patients, Kaplan–Meier survival analysis indicated that low expression level of hsa-mir-383 was significantly correlated with poor prognosis (log-rank test p-value = 0.0038), while the expression level of hsa-mir-615 or hsa-mir-877 showed no significant relationship with the prognosis (hsa-mir-615, log-rank test p-value = 0.14; hsa-mir-877, log-rank test p-value = 0.87).